Brigham and Women's Hospital Selects Toshiba's Aquilion 64 CFX.

New Agreement Opens Doors for Future Collaboration and Research

TUSTIN, Calif. -- Further reinforcing its position as a leading technology partner with research institutions across the country, Toshiba America Medical Systems, Inc. today announced a multi-year, multi-system agreement with Brigham and Women's Hospital (BWH) in Boston - one of the top five cardiac hospitals in the nation and a leader in cutting-edge research activities.

As part of the agreement, BWH has installed Toshiba's Aquilion[TM] 64 CFX CT (computed tomography) system - the cardiac CT system currently under evaluation in the CorE64 clinical trial. The Aquilion CFX will play an important role in BWH's ongoing evaluation and validation of cardiac CT as a tool for diagnosing early stage heart disease without the use of interventional procedures that can cause greater risk for the patient.

"BHW is internationally known for its treatment of complex cardiac disorders and our new Aquilion CFX will greatly improve our diagnostic and research capabilities moving forward," said Dr. Frank J. Rybicki, M.D., Ph.D., director of the Applied Imaging Science Laboratory and co-director of the Cardiovascular Imaging Section at BWH Radiology. "The system's ability to deliver precise, 0.5 mm slices and its excellent low-contrast resolution will dramatically impact the advanced cardiovascular work we do - particularly in the areas of coronary remodeling, perfusion and functional imaging."

"The system will improve more than just our contributions to the cardiovascular sector," said Steven Seltzer, chairman of the radiology department at BWH. "With Toshiba's technology, we now will be able to image other organs more precisely and provide better diagnoses for all of our patients."

According to Doug Ryan, senior director of the CT Business Unit for Toshiba, "BWH's reputation as a leader in biomedical research makes this institution an ideal partner for validating the benefits of cardiac CT and expanding our research and development in other key clinical CT studies. The commitment by BWH to our current Aquilion 64 slice CT technology and their intention to expand this further to more advanced technologies is testimony to the clinical capabilities of the Aquilion CFX CT series."

About Brigham and Women's Hospital (BWH)

BWH is a 747-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare System, an integrated health care delivery network. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. With $370 million in funding and more than 500 research scientists, BWH is an acclaimed leader in clinical, basic and epidemiological investigation - including the landmark Nurses Health Study, Physicians Health Studies and the Women's Health Initiative. For more information about BWH, visit: www.brighamandwomens.org.

About Toshiba

With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $54 billion.

Aquilion(TM)is a trademark of Toshiba Medical Systems Corporation.